Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis - ScienceDirect
Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease - Kidney International Reports
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
How to Diagnose Monoclonal Gammopathy of Undetermined Significance – Consult QD
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
JCM | Free Full-Text | Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis | PLOS ONE
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia
PDF) Renal failure due to combined cast nephropathy, amyloidosis and light- chain deposition disease
Immunoglobulin-Related Amyloidosis: Practice Essentials, Pathophysiology, Etiology
The Heavy Chain Diseases: Clinical and Pathologic Features
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text
Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL) | PLOS ONE
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management | JACC: CardioOncology
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response | Heart
Cardiac amyloidosis: a review of the literature and a practical approach for the clinicians | Italian Journal of Medicine
Frontiers | Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
Systemic amyloidosis from A (AA) to T (ATTR): a review - Muchtar - 2021 - Journal of Internal Medicine - Wiley Online Library
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis - ScienceDirect
The Heavy Chain Diseases: Clinical and Pathologic Features
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
